|
- Draws on international experience across many disciplines offering a practical approach to the topic
- Examines the latest advances in surgical and non-surgical management
- Discusses molecular studies and translational research and how they have transformed the diagnosis and management of thyroid cancer
- Addresses current challenges and areas of controversy such as low risk thyroid cancer and papillary microcarcinoma
The new edition of this book highlights the recent advances and state-of-the art in surgical and non-surgical management of thyroid cancer. Readers will learn about the latest advances and recommendations in the field, from molecular studies and biomarkers to the changing epidemiology, kinase inhibition in drug discovery and new surgical approaches, such as intra-operative neural monitoring and robotics. The management of differentiated thyroid cancer as well as childhood cancer, survivorship and clinical trial design and findings and how these fit into cancer management are discussed in detail. This comprehensive volume provides an overview of the current world literature and outlines the practical aspects of management from world leaders in this field and helps clinicians and patients on practical matters. With a selection of authors from around the world it draws on international experience giving a global perspective to the topic. Following on from the success of the first edition, it uses a multidisciplinary, evidence-based approach centered on the patient, discussing guidelines and how these have improved the quality of care and outcomes. This guide is aimed mainly at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons – Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, of course, patients. Table of Contetns- 1. Pragmatism, Precision Oncology, International Partnership for Research and Quality-The New Paradigm for Thyroid Cancer Ujjal Mallick, Clive Harmer
Section I. Multidisciplinary Approach to Management of Thyroid Cancer - 2. The UK Evidence-Based Guidelines for the Management of Thyroid Cancer: Key Recommendations
Maria G. Pavlatou, Sarah J Johnson, and Petros Perros - 3. The 2015 American Thyroid Association Evidence-Based Guidelines for Management of Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Key Recommendations
Bryan R. Haugen - 4. Thyroid Cancer: One Doctor-Patient Partnership -The Newcastle Butterfly Model
Kate A Farnell, RD Bliss, Ujjal K. Mallick
Section II. The Diagnosis of Thyroid Cancer - 5. Molecular Diagnosis of Thyroid Nodules
David N. Poller - 6. Ultrasonography in Diagnosis and Management of Thyroid Cancer -Current International Recommendations
Dong Gyu Na, Ji-Hoon Kim, Eun Ju Ha
Section III. Initial Thyroid Surgery - 7. The 21st Century Endocrine Surgeon
Nadine R. Caron, Tracy S. Wang, Cord Sturgeon, Orlo H. Clark - 8. Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer
Hiro Ishii, Dae S. Kim, John C. Watkinson - 9. Advances in Thyroid Surgery
Sara L. Richer, Dipti Kamani, GeorgeW. Randolph
Section IV. Non surgical Management of Differentiated Thyroid Cancer - 10. Risk Stratification and Current Management of Low Risk Thyroid Cancer
Sana A. Ghaznavi, R. Michael Tuttle - 11 Management of Low risk Papillary Thyroid Carcinomo and Papillary Cancer and Microcarcinoma-the Japanese experienceYasuhiro Ito and Akira Miyauchi
- 12 Radioiodine Ablation - Current Status
Furio Pacini and Maria Grazia Castagna -- Sienna - 13. Dosimetric Approaches - Current Concepts
Michael Lassmann, Markus Luster, Heribert Hanschield, Wurzberg, Germany - 14. External Radiation in Differentiated Thyroid Cancer in the era of IMRT and modern radiation planning techniques
James D. Brierley, Meredith E. Giuliani
Section V. Follow up and Longterm Management of Differentiated Thyroid Cancer - 15. Thyroglobulin
Shireen Fatemi, Carole Spencer - 16. Management of Post-Operative Hypocalcemia
Claudio Marcocci - 17. Radioiodine Refractory Thyroid Cancer
Berdelou A, Leboulleux S, Schlumberger M
Section VI. Medullary Thyroid Carcinoma - 18. Practical Management of Thyroid Cancer: A Multidisciplinary Approach Medullary Thyroid Cancer
Anna I. Kaleva ,A R Shaha, and Iain J. Nixon - 19. Medullary Thyroid Cancer: Diagnosis and Non Surgical Management
Rossella Elisei, Antonio Matrone - 20. Familial Non-Medullary Thyroid Cancer
Joanna Klubo-Gwiezdzinska, Yevgenia Kushchayeva, Sudheer Kumar Gara, Electron Kebebew
Section VII. Thyroid Cancer in Children - 21. Pediatric Differentiated Thyroid Carcinoma
Steven G. Waguespack, Jonathan D. Wasserman
Section VIII. Aggressive Thyroid Cancers - 22. Anaplastic Thyroid Cancer
Robert C. Smallridge, John Dr. Casler, and Michael E. Menefee - 23. Palliative care
Mary Comiskey
Section IX. Future Developments and Directions for Research in Thyroid Cancer - 24. Translational Research and Genomics Driven Trials in Thyroid Cancer
Maria E. Cabanillas, Rebecca E. Schweppe, Ramona Dadu, Gilbert Cote, Thomas C. Beadnell, Marie Claude Hofmann - 25. Thyroid Cancer Trials
Allan Hackshaw - 26. The Barriers to Uniform Implementation of Clinical Practice Guidelines (CPG) for Thyroid Cancer
Ujjal Mallick, Fabian Pitoia - 27. Survivorship: The Role of the Clinical Psychologist and the Clinical Nurse Specialist in Thyroid Cancer Care
Katherine Kendell, Nicola Jane Armstrong
|
